Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Rusan

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 10, 2021
Microbiology of parapharyngeal abscesses in adults: in search of the significant pathogensTejs Ehlers Klug, Thomas Greve, Camilla Andersen, et al.
International Journal of Molecular Sciences|May 27, 2026
Dual Role of Cancer Epithelial-Specific TRAF3 in Regulating Breast Cancer Cell Survival and Lymphocyte ActivityChaido Sirinian, Anne-Lise de Lastic, Harry Zaverdas, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 14, 2025
Deep targeted sequencing of circulating tumor DNA to inform treatment in patients with metastatic castration-resistant prostate cancerMaibritt Nørgaard, Maria Rusan, Karoline Kondrup, et al.
Experimental and Molecular Pathology|July 13, 2026
Intratumoral collagen correlates with histological grade and patient prognosis in breast cancerChaido Sirinian, Fabio Marchianò, Elpida Kenanidou, et al.
Molecular Cancer Therapeutics|April 15, 2018
RAS-MAPK Reactivation Facilitates Acquired Resistance in <i>FGFR1</i>-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR-MEK BlockadeBruno Bockorny, Maria Rusan, Wankun Chen, et al.
Cancer Research|December 21, 2017
ER Stress Signaling Promotes the Survival of Cancer "Persister Cells" Tolerant to EGFR Tyrosine Kinase InhibitorsHideki Terai, Shunsuke Kitajima, Danielle S Potter, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitorsLi Tan, Jun Wang, Junko Tanizaki, et al.
Nature Communications|November 21, 2025
Cross-dataset pan-cancer detection by correlating cell-free DNA fragment coverage with open chromatin sites across cell typesLudvig Renbo Olsen, Denis Odinokov, Jakob Qvortrup Holsting, et al.
Cancer Discovery|October 22, 2017
Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional RepressionMaria Rusan, Kapsok Li, Yvonne Li, et al.
Nature Communications|January 19, 2017
Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutationsYvonne Y Li, Grace T Y Chung, Vivian W Y Lui, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 10, 2021
Microbiology of parapharyngeal abscesses in adults: in search of the significant pathogensTejs Ehlers Klug, Thomas Greve, Camilla Andersen, et al.
International Journal of Molecular Sciences|May 27, 2026
Dual Role of Cancer Epithelial-Specific TRAF3 in Regulating Breast Cancer Cell Survival and Lymphocyte ActivityChaido Sirinian, Anne-Lise de Lastic, Harry Zaverdas, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 14, 2025
Deep targeted sequencing of circulating tumor DNA to inform treatment in patients with metastatic castration-resistant prostate cancerMaibritt Nørgaard, Maria Rusan, Karoline Kondrup, et al.
Experimental and Molecular Pathology|July 13, 2026
Intratumoral collagen correlates with histological grade and patient prognosis in breast cancerChaido Sirinian, Fabio Marchianò, Elpida Kenanidou, et al.
Molecular Cancer Therapeutics|April 15, 2018
RAS-MAPK Reactivation Facilitates Acquired Resistance in <i>FGFR1</i>-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR-MEK BlockadeBruno Bockorny, Maria Rusan, Wankun Chen, et al.
Cancer Research|December 21, 2017
ER Stress Signaling Promotes the Survival of Cancer "Persister Cells" Tolerant to EGFR Tyrosine Kinase InhibitorsHideki Terai, Shunsuke Kitajima, Danielle S Potter, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitorsLi Tan, Jun Wang, Junko Tanizaki, et al.
Nature Communications|November 21, 2025
Cross-dataset pan-cancer detection by correlating cell-free DNA fragment coverage with open chromatin sites across cell typesLudvig Renbo Olsen, Denis Odinokov, Jakob Qvortrup Holsting, et al.
Cancer Discovery|October 22, 2017
Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional RepressionMaria Rusan, Kapsok Li, Yvonne Li, et al.
Nature Communications|January 19, 2017
Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutationsYvonne Y Li, Grace T Y Chung, Vivian W Y Lui, et al.
Pageof 3